Work Medical Grants Shanghai Benke Exclusive East China Rights for AI Blood Cell Analyzer in RMB 10 Million Deal

Reuters

2025/12/29

Work Medical Grants Shanghai Benke Exclusive East China Rights for AI Blood Cell Analyzer in RMB 10 Million Deal

Work Medical Technology Group Ltd. announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd., has signed a one-year exclusive distribution agreement with Shanghai Benke Medical Technology Co., Ltd. Under the agreement, Shanghai Benke will promote and distribute Work Medical’s AI-Automated Blood Cell Morphology Analyzer (CM-B600) in East China, covering Jiangsu Province, Shanghai Municipality, and Zhejiang Province throughout 2026. The agreement sets a minimum annual sales target of RMB 10 million (approximately US$1.4 million). Shanghai Benke has prepaid a performance bond of RMB 1 million, which will be deducted from the final payment or refunded without interest upon meeting the sales target.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Work Medical Technology Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9617789-en) on December 29, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2595350537"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595350537\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595350537?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-29 22:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595350537","market":"nz","top_or_hot":-1,"title":"Work Medical Grants Shanghai Benke Exclusive East China Rights for AI Blood Cell Analyzer in RMB 10 Million Deal","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Work Medical Grants Shanghai Benke Exclusive East China Rights for AI Blood Cell Analyzer in RMB 10 Million Deal\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Work Medical Technology Group Ltd. announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd., has signed a one-year exclusive distribution agreement with Shanghai Benke Medical Technology Co., Ltd. Under the agreement, Shanghai Benke will promote and distribute Work Medical’s AI-Automated Blood Cell Morphology Analyzer (CM-B600) in East China, covering Jiangsu Province, Shanghai Municipality, and Zhejiang Province throughout 2026. The agreement sets a minimum annual sales target of RMB 10 million (approximately US$1.4 million). Shanghai Benke has prepaid a performance bond of RMB 1 million, which will be deducted from the final payment or refunded without interest upon meeting the sales target.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Work Medical Technology Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9617789-en) on December 29, 2025, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Work Medical Grants Shanghai Benke Exclusive East China Rights for AI Blood Cell Analyzer in RMB 10 Million Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWork Medical Grants Shanghai Benke Exclusive East China Rights for AI Blood Cell Analyzer in RMB 10 Million Deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-29 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Work Medical Grants Shanghai Benke Exclusive East China Rights for AI Blood Cell Analyzer in RMB 10 Million Deal\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Work Medical Technology Group Ltd. announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd., has signed a one-year exclusive distribution agreement with Shanghai Benke Medical Technology Co., Ltd. Under the agreement, Shanghai Benke will promote and distribute Work Medical’s AI-Automated Blood Cell Morphology Analyzer (CM-B600) in East China, covering Jiangsu Province, Shanghai Municipality, and Zhejiang Province throughout 2026. The agreement sets a minimum annual sales target of RMB 10 million (approximately US$1.4 million). Shanghai Benke has prepaid a performance bond of RMB 1 million, which will be deducted from the final payment or refunded without interest upon meeting the sales target.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Work Medical Technology Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9617789-en) on December 29, 2025, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL4cDGQn:1","article_id":"2595350537","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595350537","pubTimestamp":1767018910,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Work Medical Technology Group Ltd. announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd., has signed a one-year exclusive distribution agreement with Shanghai Benke Medical Technology Co., Ltd. Under the agreement, Shanghai Benke will promote and distribute Work Medical’s AI-Automated Blood Cell Morphology Analyzer  in East China, covering Jiangsu Province, Shanghai Municipality, and Zhejiang Province throughout 2026. The agreement sets a minimum annual sales target of RMB 10 million . Shanghai Benke has prepaid a performance bond of RMB 1 million, which will be deducted from the final payment or refunded without interest upon meeting the sales target.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Work","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4198":"医疗保健用品","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","BK4112":"金融交易所和数据","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","WOK":"WORK Medical Technology Group, Ltd.","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","NDAQ":"纳斯达克OMX交易所","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4588":"碎股"},"translate_title":"Work Medical以1000万元人民币交易授予上海奔科AI血细胞分析仪华东独家权利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WOK":0.9,"NDAQ":0.9},"content_text":"Work Medical Grants Shanghai Benke Exclusive East China Rights for AI Blood Cell Analyzer in RMB 10 Million Deal\n    \n\n        Work Medical Technology Group Ltd. announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd., has signed a one-year exclusive distribution agreement with Shanghai Benke Medical Technology Co., Ltd. Under the agreement, Shanghai Benke will promote and distribute Work Medical’s AI-Automated Blood Cell Morphology Analyzer (CM-B600) in East China, covering Jiangsu Province, Shanghai Municipality, and Zhejiang Province throughout 2026. The agreement sets a minimum annual sales target of RMB 10 million (approximately US$1.4 million). Shanghai Benke has prepaid a performance bond of RMB 1 million, which will be deducted from the final payment or refunded without interest upon meeting the sales target.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Work Medical Technology Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9617789-en) on December 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}